Nutex Health Inc. (NUTX) – What Are Investment Firms Thinking About This Stock?

Nutex Health Inc. (NASDAQ:NUTX) has received an average recommendation of “Moderate Buy” from the five research firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $323.67.

Several research firms recently commented on NUTX. Wall Street Zen cut Nutex Health from a “buy” rating to a “hold” rating in a report on Saturday. LADENBURG THALM/SH SH started coverage on shares of Nutex Health in a report on Monday, October 26th. They set a “buy” rating and a $336.00 price target for the company. Lake Street Capital reaffirmed a “buy” rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. B. Riley Financial restated a “buy” rating on shares of Nutex Health in a report on Friday, September 4th. Finally, Zacks Research cut shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th.

Nutex Health Stock Performance

Shares of NASDAQ:NUTX opened at $200.15 on Monday. Nutex Health has a 52 week low of $83.99 and a 52 week high of $226.16. The company has a quick ratio of 4.96, a current ratio of 5.00 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $1.37 billion, a P/E ratio of 7.86 and a beta of 0.66. The firm has a fifty day simple moving average of $203.24 and a two-hundred day simple moving average of $150.70.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping the consensus estimate of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The company had revenue of $210.75 million for the quarter, compared to the consensus estimate of $215.03 million. On average, analysts expect that Nutex Health will post 26.65 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Nutex Health news, Director Scott Saunders sold 203 shares of the stock in a transaction on Friday, September 18th. The stock was sold at an average price of $214.25, for a total transaction of $43,492.75. Following the transaction, the director owned 400 shares of the company’s stock, valued at $85,700. This represents a 33.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 44.68% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of NUTX. BlackRock Inc. purchased a new position in Nutex Health during the 2nd quarter worth approximately $69,612,000. Winmill & CO. Inc. acquired a new stake in shares of Nutex Health during the 2nd quarter worth approximately $11,168,000. Empowered Funds LLC acquired a new position in shares of Nutex Health in the 2nd quarter valued at $7,720,000. SG Americas Securities LLC increased its position in shares of Nutex Health by 3,232.6% during the first quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock worth $2,885,000 after acquiring an additional 29,449 shares in the last quarter. Finally, Bank of New York Mellon Corp acquired a new position in Nutex Health during the second quarter worth $3,956,000. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, medical facilities and physician practices in the United States. The company focuses on providing convenient, community-based care through its micro-hospitals and other healthcare locations.

Its hospital operations generally include emergency services, inpatient care, diagnostic testing and outpatient treatment. Nutex also operates physician networks and supports primary care and specialty providers.